BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huynh J, Marais BJ. Multidrug-resistant tuberculosis infection and disease in children: a review of new and repurposed drugs. Ther Adv Infect Dis 2019;6:2049936119864737. [PMID: 31367376 DOI: 10.1177/2049936119864737] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhou W, Yang B, Zou Y, Rahman K, Cao X, Lei Y, Lai R, Fu ZF, Chen X, Cao G. Screening of Compounds for Anti-tuberculosis Activity, and in vitro and in vivo Evaluation of Potential Candidates. Front Microbiol 2021;12:658637. [PMID: 34276592 DOI: 10.3389/fmicb.2021.658637] [Reference Citation Analysis]
2 Nataprawira HM, Septiane I, Sudarwati S, Wulandari DA. Two cases of pre-extensively drug resistant tuberculosis in children in Indonesia. Respir Med Case Rep 2021;34:101544. [PMID: 34824970 DOI: 10.1016/j.rmcr.2021.101544] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Seddon JA, Johnson S, Palmer M, van der Zalm MM, Lopez-Varela E, Hughes J, Schaaf HS. Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment. Expert Rev Respir Med 2021;15:221-37. [PMID: 32965141 DOI: 10.1080/17476348.2021.1828069] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Lee C, Bhakta S. The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review. Antibiotics (Basel) 2021;10:91. [PMID: 33477812 DOI: 10.3390/antibiotics10010091] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kozińska M, Bogucka K, Kędziora K, Szpak-szpakowska J, Pędzierska-olizarowicz W, Pustkowski A, Augustynowicz-kopeć E. XDR-TB Transmitted from Mother to 10-Month-Old Infant: Diagnostic and Therapeutic Problems. Diagnostics 2022;12:438. [DOI: 10.3390/diagnostics12020438] [Reference Citation Analysis]
6 Madzgharashvili T, Salindri AD, Magee MJ, Tukvadze N, Avaliani Z, Blumberg HM, Kempker RR, Lomtadze N. Treatment Outcomes Among Pediatric Patients With Highly Drug-Resistant Tuberculosis: The Role of New and Repurposed Second-Line Tuberculosis Drugs. J Pediatric Infect Dis Soc 2021;10:457-67. [PMID: 33347564 DOI: 10.1093/jpids/piaa139] [Reference Citation Analysis]
7 Stephanie F, Saragih M, Tambunan USF. Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment. Pharmaceutics 2021;13:592. [PMID: 33919204 DOI: 10.3390/pharmaceutics13050592] [Reference Citation Analysis]